Damir Vareslija

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Journal: BMC medicine
Published: December 13, 2025

Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy.

Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy.

Journal: ChemMedChem
Published: November 17, 2025

Response to Lehrer.

Response to Lehrer.

Journal: Journal of the National Cancer Institute
Published: November 06, 2025

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and are Clinically Relevant Across Central Nervous System Disorders.

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and are Clinically Relevant Across Central Nervous System Disorders.

Journal: Cancer research
Published: September 06, 2025

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders.

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders.

Journal: Cancer research
Published: September 06, 2025

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 15, 2025

Breast Cancer Brain Metastases: Current Understanding and Future Directions.

Breast Cancer Brain Metastases: Current Understanding and Future Directions.

Journal: Current oncology reports
Published: August 13, 2025

PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials.

PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials.

Journal: Current oncology reports
Published: March 11, 2025

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.

Journal: Journal of the National Cancer Institute
Published: February 17, 2025

Hormonal and neuronal interactions shaping the brain metastatic microenvironment.

Hormonal and neuronal interactions shaping the brain metastatic microenvironment.

Journal: Cancer letters
Published: January 30, 2025

The epigenetic landscape of brain metastasis.

The epigenetic landscape of brain metastasis.

Journal: Oncogene
Published: September 19, 2024

Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.

Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.

Journal: Cancer communications (London, England)
Published: September 10, 2024
Showing 1-12 of 41

Last Updated: 09/26/2026